Advertisement
Saturday, Dec 04, 2021
Outlook.com
Outlook.com

Health Minister Harsh Vardhan Allays Chhattisgarh's Fears About Covaxin

Chhattisgarh Health Minister T S Singh Deo said he had written to Harsh Vardhan urging him not to send Bharat Biotech's Covaxin till the phase-3 clinical trial results are completed.

Health Minister Harsh Vardhan Allays Chhattisgarh's Fears About Covaxin
| File Photo
Health Minister Harsh Vardhan Allays Chhattisgarh's Fears About Covaxin
outlookindia.com
2021-02-12T18:19:20+05:30

Resolving concerns of Chhattisgarh regarding Covid-19 vaccines and their incomplete trials, Union Health Minister Harsh Vardhan on Thursday said that both Covaxin and Covishield are vaccines are safe and immunogenic and should be used expeditiously to mitigate the impact of the pandemic. 

This comes after Chhattisgarh Health Minister T S Singh Deo said that he had written to Vardhan urging him not to send Bharat Biotech's Covaxin till the phase-3 clinical trial results are completed. He also expressed his concerns over the absence of expiry dates on the vials of the vaccine. 

Deo took to Twitter saying that the primary concerns of the state are the inhibitions regarding the incomplete third phase trials of Covaxin and the absence of expiration date on the vials of the vaccine.

"I have requested him to halt the supply of Covaxin to Chhattisgarh until these issues are addressed to the satisfaction of our Health Department to avoid the wastage of the early expiration doses of the drug," he said in another tweet.

Responding to his letter, Vardhan said he has got the matter examined in the ministry and as per New Drugs and Clinical Trials Rules, 2019, under Drugs and Cosmetics Act , 1940 and in light of urgent need due to the Covid-19 pandemic in the country, the Central Drugs Standard and Control Organisation (CDSCO) has granted permission to manufacture the two vaccines based on the prescribed procedure and after due evaluation of pre-clinical and clinical trial data.

Only those COVID-19 vaccines that have been granted permission for restricted use in emergency situations by the DCGI i.e. Covishield and Covaxin are being used for COVID-19 vaccination drive in the country.

"Both these vaccines being supplied to the states /UTs are safe and immunogenic and should be used expeditiously to rapidly confer protection to prioratised beneficiaries thereby mitigating the impact of the pandemic at the earliest," he said. "Your concern regarding unavailability of expiry date on Covaxin vial is also completely unfounded and without basis as the same is mentioned on the label of vaccine vials," Vardhan said in his letter.

He further noted that Chhattisgarh has achieved 69.87 per cent coverage of its healthcare workers by giving them the first dose of the vaccine, the state has been able to cover only 9.55 per cent of 2,09,512 frontline workers through the first dose of the vaccine.

"You would appreciate that this coverage needs to improve significantly since adequate quantities of both the vaccines are available with the state. I look forward to your continuous oversight and guidance to the ongoing COVID-19 vaccination drive in the state of Chhattisgarh which remains crucial for its success," he said.

With inputs from PTI.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Five Points On How Taliban Wants To Define Marriage For Women

Five Points On How Taliban Wants To Define Marriage For Women

Taliban government's revised version of women’s rights decree largely emphasizes on marriage and re-marriage which predictably is in accordance with the Sharia law.

Hyderpora Encounter: Arrest Of Khurram Parvez Brings Focus Back On Human Rights In Kashmir

Hyderpora Encounter: Arrest Of Khurram Parvez Brings Focus Back On Human Rights In Kashmir

Alleging abuse of anti-terror laws, the United Nations and international human rights bodies seek release of rights activist Khurram Parvez and inquiry into the Hyderpora encounter.

2nd Test, Day 2: IND Take 332-Run Lead After Dismissing NZ For 62

2nd Test, Day 2: IND Take 332-Run Lead After Dismissing NZ For 62

On Ajaz Patel's record-breaking day, India dismissed New Zealand for 62 runs, then took a 332-run lead. Catch Day 2 highlights.

Omicron Severity Is Anticipated To Be Low: Health Ministry

Omicron Severity Is Anticipated To Be Low: Health Ministry

Will the Omicron variant drive the Covid-19 third wave in India? The Union Health Ministry says the chances are very low.

Advertisement